在尤文肉瘤中,LSD1发挥了脱甲基酶独立和特定于环境的作用
Rachel D Dreher1,2,3, Cenny Taslim1, Ira Miller2,3
1Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, 43215, USA.
bioRxiv : the preprint server for biology
|December 19, 2025
概括
氨酸特异性去甲基酶1 (LSD1) 在尤宁肉瘤的进展中起着关键作用. 这项研究揭示了LSD1的酶和非酶功能,影响了基因抑制,并提出了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 由KDM1A编码的氨酸特异性去甲基酶1 (LSD1) 在尤文肉瘤中过度表达,与预后不佳相关.
- LSD1 和 EWSR1::FLI1 coprotein 在全基因组相互作用,导致 LSD1 在尤金肉瘤的进展.
- 之前对LSD1的治疗向产生了混合的结果,作用机制不清楚.
研究的目的:
- 阐明LSD1在Ewing肉瘤转录调节中的酶和非酶作用.
- 为了确定由LSD1调节的特定基因在尤文肉瘤中.
- 为了评估LSD1抑制策略的有效性,超出标准细胞毒性测试.
主要方法:
- 在各种Ewing肉瘤细胞系中利用多种消耗方法.
- 进行全基因组分析以确定LSD1受调节的基因.
- 采用了酶和非酶的LSD1活性测定.
- 使用2D细胞毒性和扩散测定与不可逆的抑制剂 (OG-L002) 调查药物反应.
主要成果:
- 确定了一个由22个基因组成的核心基因组,通常由LSD1抑制,影响突触功能和e-cadherin.
- 在LSD1丢失时观察到这些基因的减压,在所有测试的细胞系中一致.
- 由酶性与非酶性LSD1活性调节的差异化基因组.
- 发现e-cadherin向基因的抑制是由非酶性LSD1活性介导的.
- 证明标准的2D测定可能不足以评估尤宁肉瘤对LSD1抑制的反应.
结论:
- 在尤文肉瘤中,LSD1具有酶和非酶功能,有助于疾病的进展.
- LSD1的非酶作用,如调节e-cadherin,至关重要,并代表潜在的治疗点.
- 标准细胞毒性测定可能不会准确地反映Ewing肉瘤中LSD1抑制剂的治疗反应.
- 需要进一步研究染色体调节酶的非正规功能.
关键词:
尤文肉瘤 (Ewing Sarcoma) 是一种癌症.一个LSD1一个LSD1在OG-L002中,我们可以看到OG-L002.UM171 UM171 UM171 UM171 UM171 UM171 UM171 UM171 UM171 UM171 UM171 UM171 UM171其他非酶功能.翻译学 翻译学 翻译学 翻译学更多相关视频
12:18LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
6.1K
09:58An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
16.6K
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
